Consumer Health, Eighth Edition
References for Chapter 17
HIV/AIDS

  1. Hernes G. UNESCO versus HIV/AIDS: The history and ten lessons. Prospects 32(2), June 2001.
  2. Renner JH. Quoted in Segal M. Defrauding the desperate: Quackery and AIDS. FDA Consumer 21(8):17–19, 1987.
  3. Sampson WI. AIDS fraud, finances, and fringes. New York State Medical Journal of Medicine 99:92–95, 1993.
  4. A glance at the AIDS epidemic. CDC HIV/AIDS fact sheet, June 2005.
  5. Advancing HIV prevention: New strategies for a changing epidemic—United States, 2003. Morbidity and Mortality Weekly Report 53:329–332, 2003.
  6. 1993 revised classification system for HIV infection and expanded surveillance case definition for AIDS among adolescents and adults. Morbidity and Mortality Weekly Report 41 RR-17:1–19, 1992.
  7. CD4+ count. WebMDHealth Web site, April 14, 2003.
  8. HIV infection and AIDS: An overview. National Institute of Allergy and Infectious Diseases Web site, March 2005.
  9. Viral load measurement. WebMDHealth Web site, April 14, 2003.
  10. Frequently asked questions about HIV and HIV testing. National HIV Testing Resources Web site, accessed Sept 27, 2005.
  11. Centers for Disease Control and Prevention. Advancing HIV prevention: New strategies for a changing epidemic—United States, 2003. Morbidity and Mortality Weekly Report 52:329–332, 2003.
  12. Kassler WJ and others. On-site, rapid HIV testing with same-day results and counseling. AIDS 11:1045–1051, 1997.
  13. Testing yourself for HIV-1, the virus that causes AIDS—Home test system is available. FDA Web site, May 6, 1999.
  14. Defective HIV test kit marketer settles FTC charges: Kits advertised as 99.4% accurate had error rates of 59.3%. FTC news release, June 1, 2005.
  15. Cohen J. HIV data raise concern of oral-sex risk. Science 272:1421–1422, 1996.
  16. Sloand EM and others. Safety of the blood supply. JAMA 274:1368–1373, 1995.
  17. Kleinman S and others. The incidence/window period model and its use to assess the risk of transfusion-transmitted human immunodeficiency virus and hepatitis C virus infection. Transfusion Medicine Review 11:155–172, 1997.
  18. Basic statistics. CDC Web site, June 30, 2005.
  19. Condoms: Extra protection. Consumer Reports 70(2):34, 2005.
  20. Safety of nonoxynol-9 when used for contraception. Geneva, 2001, World Health Organization.
  21. Watters JK and others. Syringe and needle exchange as HIV/AIDS prevention for injection drug users. JAMA 271:115–120, 1994.
  22. Moses LE and others. Preventing HIV Transmission: The Role of Sterile Needles and Bleach. Washington, D.C., 1995, National Academy Press.
  23. Interventions to prevent HIV risk behaviors. NIH Consensus Statement 11-13;15(2):1–41, Feb 1997.
  24. Peters C. Testimony to the Massachusetts legislature's Joint Committee on Public Health, May 4, 2005.
  25. U.S. Preventive Services Task Force. Screening for HIV: Recommendation statement. Annals of Internal Medicine 143:32–37, 2005.
  26. HIV testing and pregnancy (pamphlet). Chicago, 2000, American College of Obstetricians and Gynecologists.
  27. U.S. Centers for Disease Control. Recommendation for preventing transmission of human immunodeficiency virus and hepatitis B virus to patients during exposure-prone invasive procedures. Mortality and Morbidity Weekly Report 40(RR08):1–9, 1991.
  28. Martin N. AIDS fraud rampant in Houston. Nutrition Forum 7:16, 1990.
  29. Recommended HIV treatment recommendations. AIDSinfo fact sheet, Sept 2005.
  30. Braithwaite RS and others. Estimating the proportion of patients infected with HIV who will die of comorbid diseases. American Journal of Medicine 118:890–898, 2005.
  31. Task Force on Nutrition Support in AIDS. Guidelines for nutrition support in AIDS. Nutrition Today 24(4):27–33, 1991.
  32. Schackman BR and others. The lifetime cost of HIV care in the United States in the current treatment era. Abstract WePe12.2C07 (poster). Third International AIDS Society Conference on HIV Pathogenesis and Treatment, Rio de Janeiro, Brazil, July 24–27, 2005.
  33. Barrett S. Strengthening the immune system—a growing fad. Nutrition Forum 3:24, 1986.
  34. Young FE, McIlhenny JH. AIDS: False hope from fraudulent treatment. Letter to consumer reporter, May 22, 1989.
  35. Kassler WJ and others. The use of medicinal herbs by human immunodeficiency virus-infected patients. Archives of Internal Medicine 151:2281–2288, 1991.
  36. Jobst KA and others. Safety of St. John's wort. Lancet 355:576, 2000.
  37. Lumpkin MM, Alpert S. Risk of drug interactions with St. John's wort and indinavir and other drugs. FDA Health Advisory, Feb 10, 2000.
  38. Piscitelli SC and others. The effect of garlic supplements on the pharmacokinetics of saquinavir. Clinical Infectious Diseases 34:234–238, 2002.
  39. Harris SB. The AIDS heresies: A case study in skepticism taken too far. Skeptic 3(3):42–79, 1995.
  40. The evidence that HIV causes AIDS. National Institute of Allergy and Infectious Diseases fact sheet, Feb 27, 2003.
  41. Ornstein C, Costello D. A mother's denial, a daughter's death. Los Angeles Times, Sept 24, 2005.
  42. U.S. Department of Justice. Indictments in "T-Up" Case. News release, July 7, 1999.
  43. Willis L. Man gets term of 46 months in aloe vera case: Concoction distributed as a treatment for cancer. Baltimore Sun, Dec 1, 2001.
  44. Kurzweil P. Couple imprisoned for marketing ozone generators. FDA Consumer 33(6):37–39, 1999.
  45. Massachusetts Attorney General news release, April 3, 1996.
  46. Web site promoting cure for AIDS, HIV, and arthritis. In The Enforcement Story: Fiscal Year 2001, Chapter 6. Rockville, Md., 2002, U.S. Food and Drug Administration.
  47. Medical Board of California accusation leads to surrender of Beverly Hills physician's license. Medical Board of California news release, July 5, 2005.
  48. Doctor and assistant indicted for subdosing patients on AIDS medications. U.S. Department of Justice news release, July 20, 2005.

This page was revised on October 15, 2005.

Sponsored Links to Recommended Companies